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We report the case of a 64-year-old man who had a permanent pacemaker with a unipolar silicone
electrode positioned in the right ventricle in 1989 for sinus node dysfunction. On a routine checkup in
June 2011, a 28-mm-diameter mass was discovered, which appeared to adhere to the tricuspid valve and
the ventricular lead. The size of the mass did not change for the next 6 months, and the lead impedance
was maintained at around 500–600 Ω. Because pacing failure was observed in January 2012,
he underwent an urgent pacemaker check; however, the lead impedance was found not to have
increased greatly (689 Ω). Nevertheless, the pacemaker lead was noted to be fractured at the tricuspid
level. His echocardiogram showed new severe tricuspid regurgitation and a ﬂoating mass around the
lead. We extracted the fractured lead, enucleated the tumor, replaced the tricuspid valve, and placed an
epicardial lead. Macroscopic examination revealed that the tumor surrounded the fractured lead and
covered the stump. Pathological examination revealed that the tumor was composed of ﬁbrous
connective tissue. We presumed that electric current continued to ﬂow through the stump of the
fractured unipolar lead to the generator, and this might have caused the limited increase in lead
impedance.
& 2013 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.1. Introduction
When pacemaker lead fracture occurs, the lead impedance
usually increases drastically and often becomes immeasurable [1].
Here, we experienced the case of a patient with pacemaker lead
fracture caused by a cardiac ﬁbroma in which no great change in
lead impedance was observed.2. Case report
A 64-year-old male patient underwent permanent pacemaker
implantation with a unipolar ﬁn silicone electrode (424M,
Siemens, Germany) positioned in the apex of the right ventricle
in 1989 for sinus node dysfunction.
A high echoic mass was incidentally found on a routine trans-
thoracic echocardiogram (TTE) in June 2011. The mass was 28 mm
in diameter and seemed to adhere to the tricuspid valve and a
ventricular lead (Fig. 1). The patient did not have subjective symp-
toms, and there was no evidence of infection. The pacing thresholdt Rhythm Society. Published by Els
+81 75 361 7602.and lead impedance remained unchanged compared to those
recorded 6–24 months previously. Therefore, we decided to follow
the patient carefully. He underwent TTE several times thereafter, butFig. 1. A high echoic mass of 28 mm diameter (arrows); it appeared to adhere to
the tricuspid valve and a ventricular lead. RA, right atrium; RV, right ventricle; LA,
left atrium; AV, aortic valve.
evier B.V. All rights reserved.
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every 4–6 weeks by a programmer and was maintained at around
500–600 Ω between March 2011 and January 2012.
The patient complained of dyspnea on exertion, and pacing
failure was observed on an electrocardiogram in January 2012. He
underwent urgent pacemaker check, and we found that the pace-
maker did not sense the R-wave and did not pace at all. Although
the lead impedance was only slightly increased (689 Ω), a chest
X-ray showed that the pacemaker lead was fractured at the
tricuspid level (Fig. 2). A TTE showed new severe tricuspid valve
regurgitation and a ﬂoating mass around the ventricular lead. Acute
decompensated heart failure was diagnosed, and we attemptedFig. 2. The fractured pacemaker lead (arrows) at the tricuspid level.
Fig. 3. The tumor surrounded the fractured pacemaker lead (A: generator side; B: apex
tissue with calciﬁcation (hematoxylin–eosin staining).surgical treatment. We extracted the fractured lead, enucleated the
tumor, replaced the tricuspid valve under cardiopulmonary bypass,
and implanted an epicardial lead. Macroscopic examination
revealed that the tumor surrounded the fractured lead and covered
the stump (Fig. 3A, B). Pathological examination revealed that the
tumor had no granulation, ﬁbrin agglomeration, or inﬂammatory
cell invasion but was composed of ﬁbrous connective tissue with
calciﬁcation (Fig. 3C). The tumor and the fractured lead were
subjected to bacteriological studies, and no microorganisms were
detected. Consequently, the tumor was diagnosed as a cardiac
ﬁbroma.3. Discussion
Cardiac tumors are rare and most of them are myxomas [2].
Cardiac ﬁbroma accounts for only a small percentage of all cardiac
tumors [2]. Furthermore, there have been no reports showing that
cardiac ﬁbroma may be related to pacemaker lead fracture.
The incidence of pacemaker lead fracture is about 2.6–3.6% [3,4].
However, most cases of pacemaker lead fracture occur within the
pacemaker pocket or the subclavian vein between the clavicle and
the ﬁrst rib [3,4], and fracture at the tricuspid valve level is rare [5–7].
When lead fracture occurs, the lead impedance becomes greatly
elevated and immeasurable by pacemaker telemetry [1]. However,
the present case showed only a slight increase in the lead impedance
after the fracture of the lead. Had the pacemaker lead system in this
case been bipolar, the lead impedance might have increased greatly.
We presume that an electric current continued ﬂowing through
the stump of the fractured unipolar lead to the generator, whichside) and covered the stump. (C) The tumor was composed of ﬁbrous connective
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case. In addition, a remote monitoring system was not used in this
case to measure the lead impedance. It may have been possible to
detect a partial fracture before the completion of the lead fracture if
this patient used a remote monitoring system [8,9].4. Conclusion
We report the case of a patient with pacemaker lead fracture
caused by cardiac ﬁbroma, which showed no great change in the
lead impedance.Conﬂict of interest
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